Диссертация (1141219), страница 24
Текст из файла (страница 24)
// Pediatrics – 2007 – Vol. 114 – P. 14401463.109. Nir A, Lindinger A, Rauh M, NT-pro-B-type natriuretic peptide in infants andchildren: reference values based on combined data from four studies. // PediatrCardiol. – 2009 – Vol.30 – №1– Р.3-8.110. Olsen M., Wachtell K. Cardiovascular remodeling in patient with essentialhypertension related to more high blood pressure LIFE study. // Am. Heart J. – 2012– Vol. 144 – №3 – P. 530-537.111.
Ostman-Smith I., Wettrel G., Keeton B. Age- and gender-specific mortality ratesin childhood HCM. // Eur Heart J – 2008 – Vol.29 – P.1160-1167.112. Pääkkö TJW, Perkiömäki JS, Kesäniemi YA, et al. Increasing ambulatorypulse pressure predicts the development of left ventricular hypertrophy duringlong-term follow-up. //J Hum Hypertens. – 2018 – № 7 – Р.34.113. Pagel-Langenickel I. Evolving Role of Natriuretic Peptides from DiagnosticTool to Therapeutic Modality. // Adv Exp Med Biol. – 2018 – №7 – Р.23-28.114.
Paridon SM, Alpert BS, Boas SR, et al. Clinical stress testing in the pediatric agegroup: a statement from the American Heart Association Council on CardiovascularDisease in the Young, Committee on Atherosclerosis, Hypertension, and Obesity inYouth. // Circulation - 2007 –Vol.18 – № 113 – Р.1905-20.115. Paz Suarez-Mier M. Causes of sudden death during sports activities in Spain. //Rev Esp Cardiol – 2012 – Vol. 55(4) – Р.347-58.116.
Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy ina trained athlete: differential diagnosis of physiologic athlete's heart frompathologic hypertrophy. // Prog Cardiovasc Dis. – 2012 – № 54(5) – Р.387-96.155117. Pettersen MD, Du W, Skeens ME, et al. Regression equations for calculation ofz-scores of cardiac structures in a large cohort of healthy infants, children, andadolescents: an echocardiographic study. // J Am Soc Echocardiogr.
– 2008 – Vol.21(8) – P.922-34.118. Priori S.G. Task force on SCD of the European Society of cardiology. // Eur.Heart Journal – 2011 – Vol. 22 – P. 1374-1450.119. Quigley F., et.al. A survey of the causes of sudden death in sport in the Republicof Ireland. // Br. J Sports Med – 2007 – Vol.34 – P.258-61.120. Richard P., Charron P. HCM: distribution of disease genes, spectrum ofmutation, and implication for a molecular diagnosis strategy.
// Circulation – 2013– Vol.107 – P. 2227-2232.121. RocaF,IacobM,Remy-JouetI,etal.Evidenceforaroleof vascular endothelium in the control of arterial wall viscosity in humans. //Hypertension – 2018 – № 71(1) – Р.143-150.122. Romano A., Allanson J. Noonan syndrome: clinical futures, diagnosis andmanagement guidelines. // Pediatrics – 2010 – Vol.126 – №4 – Р.746-759.123. Rubattu S., Volpe M. Discovering a new role for the atrial natriuretic peptide: Anovel risk factor for cardiovascular.
//Heart Int. – 2007 – №2 (2) – Р.78.124. Rubattu S, Sciarretta S, Valenti V, et al. Natriuretic peptides: an update onbioactivity, potential therapeutic use, and implication in cardiovascular diseases. //Am J Hypertens. – 2008 – Vol. 21(7) – P.733-41.125. Sakata K, Ino H, Yamagishi M., et al.
Exercise-induced systolic dysfunction inpatients with non-obstructive hypertrophic cardiomyopathy and mutations in thecardiac troponin genes. // Heart. – 2008 – Vol. 94(10) – P.1282-7.126. SamesimaN,AzevedoLF,DeMatosLDNJ,Comparisonofelectrocardiographic criteria for identifying left ventricular hypertrophy in athletesfrom different sports modalities. // Clinics (Sao Paulo). – 2017 – №72(6) – Р.343350.156127. Sarto P, Merlo L, Noventa D, et al. Electrocardiographic changes associatedwith training and discontinuation of training in an athlete with hypertrophiccardiomyopathy. // Am J Cardiol. – 2014 – Vol. 93(4) – №15 – P.518-9.128.
Sauer A, Wilcox JE, Andrei AC, et al. Diastolic electromechanical coupling:association of the ECG T-peak to T-end interval with echocardiographic markers ofdiastolic dysfunction. // Circ Arrhythm Electrophysiol. – 2012 – №5(3) – Р.537-43.129. Scaglia F., Towbin J.A., Craigen W.J., Clinical spectrum, morbidity in 113pediatric patient with mitochondrial disease.
// Pediatrics – 2004 – Vol.114 – №4 –Р. 925-931.130. Shenasa M, Shenasa H. Hypertension, left ventricular hypertrophy, andsudden cardiac death. // Int J Cardiol. – 2017 – Vol.237 – № 15 –P.60-63.131.Shimizu M., Ino H., Okeie K. T-peak to T-end interval may be a better predictorof high risk patients with HCM associated with a cardiac troponin I mutation thanQT dispersion.
// Clin cardiol. – 2012 – Vol. 25 – P.335-9.132. Sorof J., Alexandrov A., Carwell G. Carotid artery intimal-medial thickness andleft ventricular hypertrophy in children with elevated BP. // Pediatrics. – 2013 –Vol.111 – P.61-68.133. Spagnolo A, Giussani M, Ambruzzi AM, et al. Focus on prevention, diagnosisand treatment of hypertension in children and adolescents // Ital J Pediatr. – 2013 –№ 19 – Vol.39 – P. 20.134.
Spriet LL, Perry CG, Talanian JL. Legal pre-event nutritional supplements toassist energy metabolism. // Essays Biochem. – 2008 – Vol.44 – Р. 27- 43.135. Tabib A., et al. Undetected cardiac lesions cause unexpected SCD duringoccasional sport activity.
A report on 80 cases. // Eur Heart J – 1999 – Vol. 20 –Р.900-903.136. Tan LH, Jefferies JL, Liang JF, et al. Concentrations of brain natriuretic peptidein the plasma predicts outcomes of treatment of children with decompensated heartfailure admitted to the Intensive Care unit. // Cardiol Young. – 2007 – №17(4) –Р.397-406.157137.
Taquiso JL, Obillos SMO, Mojica JV, et al. Systolic Anterior Motion of MitralValve Subchordal Apparatus: A Rare Echocardiographic Pattern in NonObstructive Hypertrophic Cardiomyopathy. // Cardiol Res. – 2017 – № 8(5) –Р.258-264.138. Tartaglia M., Gelb B.D. Disorders of dysregulated signal traffic through theRAS-MAPK pathway: phenotypic spectrum and molecular mechanisms. // Ann NY Acad Sci – 2010 – Vol.1214 – P. 99-121.139.
Ternacle J, Bremont C, d'Humieres T, et al. Left ventricular dyssynchrony and2D and 3D global longitudinal strain for differentiating physiological andpathological left ventricular hypertrophy. // Arch Cardiovasc Dis. – 2017 –№110(6-7) – Р.403-412.140. Topilski I, Rogowski O, Rosso R, et al. The morphology of the QT intervalpredicts torsade de pointes during acquired brady arrhythmias. // J Am CollCardiol. – 2007 – Vol. 49(3) – P. 320–328.141. Tsao CW, Gona PN, Salton CJ, et al. Left Ventricular Structure and Risk ofCardiovascular Events: A Framingham Heart Study. // J Am Heart Assoc.
– 2015 –№ 15 – Р.4(9).142. Van Camp Nontraumatic sports death in high school and college athletes. // MedSci Sports Exerc. – 1995 – Vol. 27(5) – P. 641-7.143. Uchiyama K, Hayashi K, Fujino N, et al. Impact of QT variables on clinicaloutcome of genotyped hypertrophic cardiomyopathy. // Ann NoninvasiveElectrocardiol. – 2009 – Vol.14(1) – Р.65-71.144. Vassalle C, Andreassi MG. Genetic polymorphisms of the natriuretic peptidesystem in the pathogenesis of cardiovascular disease: what lies on the horizon? //Clin Chem. – 2009 – Vol.
55(5) – P.878-87.145. Verdeccbia P., Porcellati C. Left ventricular hypertrophy as independentpredictor of acute cerebrovasculal events in essential hypertension. // Circulation –2008 – Vol.104 – P. 239-244.146. Viitasalo M, Oikarinen L, Väänänen H, et al. U-waves and T-wave peak to Twave end intervals in patients with catecholaminergic polymorphic ventricular158tachycardia, effects of beta-blockers. // Heart Rhythm. – 2008 – №5(10) – Р.13828.147. Viliani D, Pozo E, Aguirre N, et al.
Helical distribution of hypertrophy inpatients with hypertrophic cardiomyopathy: prevalence and clinical implications. //Int J Cardiovasc Imaging. – 2017 – № 33(11) – Р.1771-1780.148. Volpe M, Rubattu S, Burnett J Jr. Natriuretic peptides in cardiovasculardiseases: current use and perspectives. // Eur Heart J. – 2014 – Vol. 35(7) – P.41925.149. WagnerGS,recommendationsMacfarlanefortheP,WellensstandardizationH,andetal.AHA/ACCF/HRSinterpretationoftheelectrocardiogram: part VI: acute ischemia/infarction: a scientific statement fromthe American Heart Association Electrocardiography and Arrhythmias Committee,Council on Clinical Cardiology; the American College of Cardiology Foundation;and the Heart Rhythm Society: endorsed by the International Society forComputerizedElectrocardiology.AmericanHeartAssociation Electrocardiography and Arrhythmias Committee, Council on ClinicalCardiology; American College of Cardiology Foundation; Heart Rhythm Society.// Circulation.
– 2009 – Vol. 119(10) – № 17 –– P.262-70.150. Waks JW, Buxton AE. Risk Stratification for Sudden Cardiac Death AfterMyocardial Infarction. // Annu Rev Med. - 2018 – Vol.69 - №29– P.147-164.151. Wald R, Veldtman G, Golding F. Determinants of outcome in isolatedventricular noncompaction in childhood. // Am J Cardiol. – 2008 – Vol.
15 – №94– Р.1581-4.152. Wei H., Pang-Hu Z, Xiao-Bin Z. Plasma concentrations of adrenomedullin andnatriuretic peptides in patients with essential hypertension. // Exp. Ther Med. – 2015– Vol. 9 – №5 – Р. 1901–1908.153. Woroniecki RP, Kahnauth A, Panesar LE, et al. Left Ventricular Hypertrophy inPediatric Hypertension: A Mini Review. // Front Pediatr. – 2017 – Vol.5 – №11 –P.101.159154. Xia Y, Liang Y, Kongstad O., et al. T peak-Tend interval as an index of globaldispersion of ventricular repolarization: evaluations using monophasic actionpotential mapping of the epi- and endocardium in swine. // J Interv CardElectrophysiol.
– 2008 – Vol. 14(2) – P.79-87.155. Yamaguchi M, Shimizu M, Ino H et al. T wave peak-to-end interval and QTdispersion in acquired long QT syndrome: a new index for arrhythmogenicity. //Clin Sci (Lond). – 2008 – Vol. 105(6) – P. 671-6.156. Yoshimura M., Mizuno Y., Nakamura M. et al. B-type natriuretic peptide as amarker of the effects of enalapril-4 in patients with heart fealure. // Amer.
J. Med.– 2012 – Vol. 12 – № 9 – P. 716–720.157. Zoghi M, Gürgün C, Yavuzgil O, et al. QT dispersion in patients with differentetiologies of left ventricular hypertrophy: the significance of QT dispersion inendurance athletes. // Int J Cardiol. – 2012 – Vol. 84(2-3) – P.153-15.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
